Executive Summary
Maximizing prices and securing reimbursement status for a product is increasing in importance, as pharmaceutical companies seek to ensure that they achieve a high return on investment from current and future drugs in light of a sustained R&D productivity shortfall and a wave of impending blockbuster patent expiries. Pharmaceutical Pricing Strategies: Price optimization, reimbursement and regulation in Europe, US and Japan, is a report which will help you create an effective pricing policy, in the midst of continued regulatory uncertainty, stagnant R&D and the continued cost-containment efforts of healthcare payors. This report will provide detailed analysis of the key issues and market environments making up the pricing landscape, and enable you to conduct pricing and reimbursement evaluations for products throughout the development lifecycle. Gain a detailed understanding a drug’s potential price profile and optimize future returns by including these assessments in portfolio evaluations and lifecycle planning, with the help of this report.
Other selected research from the 'Pharmacoeconomics' category:
Addressing Patient Compliance: Targeted marketing driving a shift in focus from acquisition to retention
Personalizing Disease Management through Technology Solutions: Part I
Other selected research from the 'Regulation & Policy' category:
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
Advances in the Design and Regulation of Adaptive Clinical Trials